Fortis takes over 200-bed Greater Noida hospital on long term lease
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
Generic Saxenda is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the US market
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
The company is bringing precision therapies for gynaecological cancers
The company has improved access to quality healthcare for seniors across both urban and rural areas
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Subscribe To Our Newsletter & Stay Updated